Abstract
Hypertension, the leading cause of mortality and the third largest cause of disability, is poorly controlled worldwide. The failure to control hypertension takes an unacceptable toll on patients and their families. In addition to the personal cost, to the individual patient, uncontrolled hypertension creates huge, avoidable economic burdens when viewed in terms of the general population. Almost one-half of patients drop out entirely from treatment within 1 year. This review summarizes key challenges related to hypertension management with special focus on patient compliance. Firstly, we will present consequences of poor blood pressure control. Secondly, methods of patient compliance assessment will be reviewed. Thirdly, we will present recent studies assessing adherence with hypertension treatment. Finally, we will review potential solutions to improve patient compliance and blood pressure control which are of crucial importance for reduction of hypertension-related morbidity and mortality.
Keywords: Hypertension, treatment, compliance, cardiovascular, stroke, ischaemic heart disease, high blood pressure, antihypertensive drugs, Avoiding Cardiovascular Events in Combination Therapy in Patients Living with Systolic Hypertension), cardiovascular disease, therapeutic inertia, PATIENT COMPLIANCE, antihypertensive drug treat-ment, renin-angiotensin system, white-coat adher-ence, Arterial Hypertension, European Society of Hypertension, European Society of Cardiology, cardiovascular health, Control Hypertension Study
Current Vascular Pharmacology
Title: Improving Patient Compliance with Hypertension Treatment: Mission Possible?
Volume: 8 Issue: 6
Author(s): Marzena Chrostowska and Krzysztof Narkiewicz
Affiliation:
Keywords: Hypertension, treatment, compliance, cardiovascular, stroke, ischaemic heart disease, high blood pressure, antihypertensive drugs, Avoiding Cardiovascular Events in Combination Therapy in Patients Living with Systolic Hypertension), cardiovascular disease, therapeutic inertia, PATIENT COMPLIANCE, antihypertensive drug treat-ment, renin-angiotensin system, white-coat adher-ence, Arterial Hypertension, European Society of Hypertension, European Society of Cardiology, cardiovascular health, Control Hypertension Study
Abstract: Hypertension, the leading cause of mortality and the third largest cause of disability, is poorly controlled worldwide. The failure to control hypertension takes an unacceptable toll on patients and their families. In addition to the personal cost, to the individual patient, uncontrolled hypertension creates huge, avoidable economic burdens when viewed in terms of the general population. Almost one-half of patients drop out entirely from treatment within 1 year. This review summarizes key challenges related to hypertension management with special focus on patient compliance. Firstly, we will present consequences of poor blood pressure control. Secondly, methods of patient compliance assessment will be reviewed. Thirdly, we will present recent studies assessing adherence with hypertension treatment. Finally, we will review potential solutions to improve patient compliance and blood pressure control which are of crucial importance for reduction of hypertension-related morbidity and mortality.
Export Options
About this article
Cite this article as:
Chrostowska Marzena and Narkiewicz Krzysztof, Improving Patient Compliance with Hypertension Treatment: Mission Possible?, Current Vascular Pharmacology 2010; 8 (6) . https://dx.doi.org/10.2174/157016110793563799
DOI https://dx.doi.org/10.2174/157016110793563799 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Strategy for Synthesis of Anticancer Active Piperastrol, Enastron Using Ammonium Sulfocyanate
Letters in Organic Chemistry Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family
Current Protein & Peptide Science Novel Anticancer Targets and Drug Discovery in Post Genomic Age
Current Medicinal Chemistry - Anti-Cancer Agents Mediterranean Diet and Hypertension; From the Clinical and Epidemiologic Evidences to Prevention
Current Hypertension Reviews Application of Central Composite Design in Optimization of Valsartan Nanosuspension to Enhance its Solubility and Stability
Current Drug Delivery Use and Results of Antidepressant Treatment: Patients' Perception
Current Drug Therapy Adjuvant Therapies of COVID-19 - A Literature Review
Coronaviruses Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema – An Overlooked Adverse Drug Reaction?
Current Diabetes Reviews Screening and Preponderance of Peptic Ulcer and its Contributing Risk Factors Among Basrah City Residents in Iraq
Current Drug Safety Carotid Endarterectomy and Carotid Artery Stenting Lead to Improved Cognitive Performance in Patients with Severe Carotid Artery Stenosis
Current Neurovascular Research Vasopressin Secretion Control: Central Neural Pathways, Neurotransmitters and Effects of Drugs
Current Pharmaceutical Design Renal Innervation in Resistant Hypertension: A Review of Pathophysiology and Renal Denervation as Potential Treatment
Current Hypertension Reviews Salvianolic Acid B Inhibits Atherogenesis of Vascular Cells through Induction of Nrf2-dependent Heme Oxygenase-1
Current Medicinal Chemistry Activation of the Renin-angiotensin System could Cause Hypertension During Fasting in Muslims in the Month of Ramadhan
Current Hypertension Reviews Current Drug Nano-targeting Strategies for Improvement in the Diagnosis and Treatment of Prevalent Pathologies such as Cardiovascular and Renal Diseases
Current Drug Targets Integrative Control of Gastrointestinal Motility by Nitric Oxide
Current Medicinal Chemistry Resveratrol and Stroke: from Chemistry to Medicine
Current Neurovascular Research High Throughput Metabolomics in Clinical Studies: Review and New Applications to Remote Ischemic Preconditioning
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Cardiovascular & Hematological Disorders-Drug Targets